EXCELIMMUNE Trademark

Trademark Overview

On Wednesday, September 15, 2010, a trademark application was filed for EXCELIMMUNE with the United States Patent and Trademark Office. The USPTO has given the EXCELIMMUNE trademark a serial number of 85130242. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, August 4, 2014. This trademark is owned by Excelimmune, Inc. The EXCELIMMUNE trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development in the pharmaceutical and biotechnology fields; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; Research and development and consultation related thereto in the field of human recombinant polyclonal antibodies; Software as a service (SAAS) services featuring software for medical diagnosis or scientific analysis in the field of human recombinant polyclonal antibodies; Software development and software consultation services related to the field of human recombinant polyclonal antibodies
excelimmune

General Information

Serial Number85130242
Word MarkEXCELIMMUNE
Filing DateWednesday, September 15, 2010
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, August 4, 2014
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 3, 2011

Trademark Statements

Goods and ServicesResearch and development in the pharmaceutical and biotechnology fields; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; Research and development and consultation related thereto in the field of human recombinant polyclonal antibodies; Software as a service (SAAS) services featuring software for medical diagnosis or scientific analysis in the field of human recombinant polyclonal antibodies; Software development and software consultation services related to the field of human recombinant polyclonal antibodies
Pseudo MarkEXCEL IMMUNE

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, September 20, 2010
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameExcelimmune, Inc
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWoburn, MA 01801
Party NameExcelimmune, Inc
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSomerville, MA 02143

Trademark Events

Event DateEvent Description
Monday, August 4, 2014ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, August 4, 2014ABANDONMENT - NO USE STATEMENT FILED
Tuesday, January 14, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, January 13, 2014EXTENSION 5 GRANTED
Monday, December 30, 2013EXTENSION 5 FILED
Monday, December 30, 2013TEAS EXTENSION RECEIVED
Wednesday, June 26, 2013ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, June 26, 2013TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, June 4, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 3, 2013EXTENSION 4 GRANTED
Friday, May 31, 2013EXTENSION 4 FILED
Friday, May 31, 2013TEAS EXTENSION RECEIVED
Tuesday, December 18, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 17, 2012EXTENSION 3 GRANTED
Friday, December 14, 2012EXTENSION 3 FILED
Friday, December 14, 2012TEAS EXTENSION RECEIVED
Wednesday, June 27, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 26, 2012EXTENSION 2 GRANTED
Monday, June 25, 2012EXTENSION 2 FILED
Monday, June 25, 2012TEAS EXTENSION RECEIVED
Tuesday, April 24, 2012TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, December 13, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 12, 2011EXTENSION 1 GRANTED
Friday, December 2, 2011EXTENSION 1 FILED
Monday, December 12, 2011CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, December 2, 2011TEAS EXTENSION RECEIVED
Tuesday, June 28, 2011NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 3, 2011OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 3, 2011PUBLISHED FOR OPPOSITION
Monday, March 28, 2011LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, March 28, 2011ASSIGNED TO LIE
Friday, March 11, 2011APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, March 10, 2011TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, March 10, 2011CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, March 10, 2011TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, December 28, 2010NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, December 28, 2010NON-FINAL ACTION E-MAILED
Tuesday, December 28, 2010NON-FINAL ACTION WRITTEN
Wednesday, December 22, 2010ASSIGNED TO EXAMINER
Tuesday, September 21, 2010NOTICE OF PSEUDO MARK MAILED
Monday, September 20, 2010NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, September 18, 2010NEW APPLICATION ENTERED IN TRAM

Related Keywords

excelimmune software development recombinant polyclonal human research antibodies services field pharmaceutical